These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15961013)

  • 1. Methadone-induced bradycardia.
    Ashwath ML; Ajjan M; Culclasure T
    J Emerg Med; 2005 Jul; 29(1):73-5. PubMed ID: 15961013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syncope: a tale of two triggers.
    Katz DF; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 Sep; 173(16):1543-4. PubMed ID: 24030761
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of methadone treatment on cardiac repolarization and conduction in opioid users.
    Martell BA; Arnsten JH; Krantz MJ; Gourevitch MN
    Am J Cardiol; 2005 Apr; 95(7):915-8. PubMed ID: 15781034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradycardia associated with intravenous methadone administered for sedation in a patient with acute respiratory distress syndrome.
    Karir V
    Pharmacotherapy; 2002 Sep; 22(9):1196-9. PubMed ID: 12222559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Life-threatening, recurrent arrhythmia in patients on high-dose methadone treatment: torsade de pointes].
    Al-Shakarshi JS; Bent-Hansen L; Jensen GB
    Ugeskr Laeger; 2004 Aug; 166(36):3104-5. PubMed ID: 15387312
    [No Abstract]   [Full Text] [Related]  

  • 6. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a dose increase on chronic opiate use during methadone detoxification.
    Stitzer ML; McCaul ME; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984; 55():197-201. PubMed ID: 6443379
    [No Abstract]   [Full Text] [Related]  

  • 9. Marked Symptomatic Sinus Bradycardia With New Onset First-Degree Atrioventricular Block After Concomitant Methadone and Trazodone Use.
    Saeed M; Tripathi D; Chaudhari S
    Am J Ther; 2018; 25(5):e575-e577. PubMed ID: 28953513
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic methadone therapy complicated by torsades de pointes: a case report.
    Pimentel L; Mayo D
    J Emerg Med; 2008 Apr; 34(3):287-90. PubMed ID: 18022786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance dosing guideline for opioid dependence, a literature review.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Addict Dis; 2010 Jan; 29(1):1-14. PubMed ID: 20390694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
    Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methadone-induced heart arrhythmia].
    Østvold C; Topper M
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2021-2. PubMed ID: 16100543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and torsade de pointes: case report and review of the literature.
    Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA
    Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiological investigation into an outbreak of rash illness among methadone maintenance clients in Australia.
    McAnulty JM; Jauncey ME; Monger CK; Hailstone ST; Alam NK; Mannes TF; Capon AG; Irvine K; Armstrong PK; Kaldor JM
    Drug Alcohol Rev; 2007 May; 26(3):321-31. PubMed ID: 17454022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.